These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


712 related items for PubMed ID: 11841694

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The FcRgamma chain is not essential for induction of experimental allergic encephalomyelitis (EAE) or anti-myelin antibody-mediated exacerbation of EAE.
    Breij EC, Heijnen P, Vloet R, Saito T, van de Winkel JG, Dijkstra CD, Amor S, Verbeek S.
    J Neuropathol Exp Neurol; 2005 Apr; 64(4):304-11. PubMed ID: 15835266
    [Abstract] [Full Text] [Related]

  • 3. IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein.
    Okuda Y, Sakoda S, Bernard CC, Fujimura H, Saeki Y, Kishimoto T, Yanagihara T.
    Int Immunol; 1998 May; 10(5):703-8. PubMed ID: 9645618
    [Abstract] [Full Text] [Related]

  • 4. Infection with Mycobacterium bovis BCG diverts traffic of myelin oligodendroglial glycoprotein autoantigen-specific T cells away from the central nervous system and ameliorates experimental autoimmune encephalomyelitis.
    Sewell DL, Reinke EK, Co DO, Hogan LH, Fritz RB, Sandor M, Fabry Z.
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):564-72. PubMed ID: 12853387
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparing the pathogenesis of experimental autoimmune encephalomyelitis in CD4-/- and CD8-/- DBA/1 mice defines qualitative roles of different T cell subsets.
    Abdul-Majid KB, Wefer J, Stadelmann C, Stefferl A, Lassmann H, Olsson T, Harris RA.
    J Neuroimmunol; 2003 Aug; 141(1-2):10-9. PubMed ID: 12965249
    [Abstract] [Full Text] [Related]

  • 8. Pathological and regulatory effects of anti-myelin antibodies in experimental allergic encephalomyelitis in mice.
    Morris-Downes MM, Smith PA, Rundle JL, Piddlesden SJ, Baker D, Pham-Dinh D, Heijmans N, Amor S.
    J Neuroimmunol; 2002 Apr; 125(1-2):114-24. PubMed ID: 11960647
    [Abstract] [Full Text] [Related]

  • 9. Vaccination with myelin oligodendrocyte glycoprotein adsorbed to alum effectively protects DBA/1 mice from experimental autoimmune encephalomyelitis.
    Wållberg M, Wefer J, Harris RA.
    Eur J Immunol; 2003 Jun; 33(6):1539-47. PubMed ID: 12778471
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis.
    Juedes AE, Ruddle NH.
    J Immunol; 2001 Apr 15; 166(8):5168-75. PubMed ID: 11290800
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Role of pathogenic T cells and autoantibodies in relapse and progression of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in LEW.1AV1 rats.
    Matsumoto Y, Park IK, Hiraki K, Ohtani S, Kohyama K.
    Immunology; 2009 Sep 15; 128(1 Suppl):e250-61. PubMed ID: 19175799
    [Abstract] [Full Text] [Related]

  • 17. The myelin oligodendrocyte glycoprotein (MOG): a model for antibody-mediated demyelination in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Stefferl A, Brehm U, Linington C.
    J Neural Transm Suppl; 2000 Sep 15; (58):123-33. PubMed ID: 11128602
    [Abstract] [Full Text] [Related]

  • 18. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination.
    Gran B, Zhang GX, Yu S, Li J, Chen XH, Ventura ES, Kamoun M, Rostami A.
    J Immunol; 2002 Dec 15; 169(12):7104-10. PubMed ID: 12471147
    [Abstract] [Full Text] [Related]

  • 19. Cutting edge: both activating and inhibitory Fc receptors expressed on mast cells regulate experimental allergic encephalomyelitis disease severity.
    Robbie-Ryan M, Tanzola MB, Secor VH, Brown MA.
    J Immunol; 2003 Feb 15; 170(4):1630-4. PubMed ID: 12574324
    [Abstract] [Full Text] [Related]

  • 20. Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE.
    Eltayeb S, Berg AL, Lassmann H, Wallström E, Nilsson M, Olsson T, Ericsson-Dahlstrand A, Sunnemark D.
    J Neuroinflammation; 2007 May 07; 4():14. PubMed ID: 17484785
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 36.